Jadersten, M., Pellagatti, A., Forsblom, A., Emanuelsson, E., Merup, M., Samuelsson, J., . . . Hellstorm-Lindberg, E. (2005). Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.
Citace podle Chicago (17th ed.)Jadersten, M., A. Pellagatti, A. Forsblom, E. Emanuelsson, M. Merup, J. Samuelsson, J. Wainscoat, J. Boultwood, a E. Hellstorm-Lindberg. Lenalidomide Selectively Inhibits in Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome (MDS) Patients with 5q Deletion. 2005.
Citace podle MLA (9th ed.)Jadersten, M., et al. Lenalidomide Selectively Inhibits in Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome (MDS) Patients with 5q Deletion. 2005.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..